These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 21924648

  • 21. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT, Hsu KF, Shieh GS, Lo CW, Chang CC, Wu CL, Shiau AL.
    Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754
    [Abstract] [Full Text] [Related]

  • 22. Irradiated Bladder Cancer Cells Expressing both GM-CSF and IL-21 versus Either GM-CSF or IL-21 Alone as Tumor Vaccine in a Mouse Xenograft Model.
    Peng J, Ye L, Li T, Zhu Q, Guo J, Xiao K, Wei Y.
    Biomed Res Int; 2019 Nov; 2019():8262989. PubMed ID: 31467912
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer.
    Shi X, Zhang X, Li J, Zhao H, Mo L, Shi X, Hu Z, Gao J, Tan W.
    Cancer Lett; 2017 Oct 10; 406():27-35. PubMed ID: 28797844
    [Abstract] [Full Text] [Related]

  • 25. Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.
    Miguel A, Herrero MJ, Sendra L, Botella R, Algás R, Sánchez M, Aliño SF.
    Cancer Gene Ther; 2013 Oct 10; 20(10):576-81. PubMed ID: 23969885
    [Abstract] [Full Text] [Related]

  • 26. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J, Wu JH, Bouganim N, Galipeau J.
    Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233
    [Abstract] [Full Text] [Related]

  • 27. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
    Ho MY, Sun GH, Leu SJ, Ka SM, Tang SJ, Sun KH.
    Int J Cancer; 2008 Jul 01; 123(1):123-33. PubMed ID: 18386791
    [Abstract] [Full Text] [Related]

  • 28. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
    Chu Y, Wang LX, Yang G, Ross HJ, Urba WJ, Prell R, Jooss K, Xiong S, Hu HM.
    J Immunother; 2006 Dec 15; 29(4):367-80. PubMed ID: 16799332
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.
    Liu B, Tan W, Barsoum A, Gu X, Chen K, Huang W, Ramsay A, Kolls JK, Schwarzenberger P.
    Exp Hematol; 2010 Oct 15; 38(10):877-884.e1. PubMed ID: 20600582
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov 15; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 36. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S, Bartholomew RM, Pezzoli P, Gutierrez A, Gouveia E, Bassett D, Soo Hoo W, Carlo DJ.
    Gene Ther; 2002 Oct 15; 9(19):1302-11. PubMed ID: 12224013
    [Abstract] [Full Text] [Related]

  • 37. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 38. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H, Abe J, Tsunoda R, Aoyagi M, Hirakawa K, Hamada H.
    Cancer Res; 1996 Apr 15; 56(8):1828-33. PubMed ID: 8620500
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
    Choi KJ, Zhang SN, Choi IK, Kim JS, Yun CO.
    Gene Ther; 2012 Jul 15; 19(7):711-23. PubMed ID: 21993173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.